Gaia Bio

Genetically Modified Bacteria

Industrial Technologies
Private

Company Overview

Snapshot

Founded in December 2021 by Nikita Shenkar, Gaia Bio operates with 1–10 employees. The company has secured funding across three rounds from one investor, VentureIsrael, which participated in a funding round in September 2025.

Business overview

Gaia Bio specializes in industrial technologies, leveraging advanced gene editing to enhance precision fermentation, bacterial bioremediation, and biomining processes. The company's core technology focuses on engineering a diverse range of environmental and wild-type bacteria, a critical capability for applications requiring bacteria to thrive in challenging conditions like acidic environments. This approach aims to significantly increase the yield of bacteria-based products and serves industries such as wastewater treatment, plastics recycling, alternative energy, sustainable chemicals, and metals recovery.

Company Intelligence Q&A

What is Gaia Bio's core technology?
Gaia Bio utilizes a new gene editing technology and proprietary methodology to engineer a wide array of environmental and wild-type bacteria. This enables the company to drastically increase the yields of precision fermentation processes and enhance the effectiveness of bacterial bioremediation and biomining applications.
Which industries does Gaia Bio target with its genetically modified bacteria?
Gaia Bio's genetically modified bacteria are designed for use across various industries, including wastewater treatment, plastic and pollution treatment, alternative batteries, fuel cells, sustainable chemicals, metals recovery and refinery (including gold and lithium), nitrogen fixation, sustainable fertilizers, and sustainable food and cosmetic products.
When was Gaia Bio founded?
Gaia Bio was founded in December 2021.
Who is a key founder of Gaia Bio?
Nikita Shenkar is a co-founder and CEO of Gaia Bio.
Has Gaia Bio received any funding?
Gaia Bio has secured funding across three rounds. VentureIsrael participated in a funding round in September 2025 and also in October 2024.

External links